Boron Neutron Capture Therapy
不可能に、挑む治療を。今日のために、未来のために。
最も治療が難しいがんに、世界水準の放射線腫瘍学で向き合います。未来のためにホウ素中性子捕捉療法（BNCT）を切り拓き、今日の最も困難な症例で臨床医に助言し、日本の医療企業を欧州へとつなぎます。
Boron Neutron Capture Therapy
一つの専門性が拓く、三つのフロンティア。
BNCT Globalは、40年にわたる放射線腫瘍学のリーダーシップを、一つの信念を共有する三つの使命に注いでいます。医学が最も苦しむ患者にこそ、最も深い専門知識が届けられるべきである、という信念です。未来のためにホウ素中性子捕捉療法（BNCT）を切り拓き、いま治療されている最も困難な症例で臨床医に助言し、日本の医療企業を欧州市場へとつなぎます。
未来へ
BNCTネットワーク。世界で築かれつつある、治療の新しい標準。
今日を
答えの尽きた放射線腫瘍学の症例に、専門家の助言を。
国境を越えて
ドイツ市場に参入する医療企業のための、日本と欧州の架け橋。
人
三つの事業を支える、一つの礎。
Prof. Dr. med. Wolfgang Sauerwein
創業者・プレジデント（BNCT Global GmbH）
腫瘍学、物理学、化学、産業界の16名の国際的リーダーからなるアドバイザリーボードが支えています。
経営陣
日々の経営を担う、人。
創業者Prof. Sauerweinとともに、2名の業務執行取締役が事業運営、提携、成長を率いています。
André Minne
業務執行取締役 兼 最高財務責任者（CFO）
André Minneは、ドイツの税理士資格（Steuerberater）およびDiplom-Finanzwirtの称号を持つ財務の専門家です。税務行政での勤務を経て、ドイツのDAX上場企業の税務部門で要職を歴任。ロンドンでの国際教育課程とドイツ税理士試験を修了し、複数の企業で業務執行取締役を務めました。2002年からは税理士事務所のパートナーとして、税務およびそれに関連する経営課題について、ジェネラリストとして顧客に助言しています。
Dr. Christian Köster
業務執行取締役 兼 最高法務責任者（CLO）
Dr. Christian Kösterは、企業内弁護士および社外法律顧問として30年以上の経験を持ち、世界各国の弁護士と協働してきました。IT・データ保護法、国際取引法、M&A、ジョイントベンチャー、独占禁止法や輸出管理を含むコンプライアンス、訴訟に深い知見を持つリーガル・ジェネラリストです。製造、化学、ヘルスケア、小売、ファッションの各業界で、EMEA全域のプロジェクトを経験し、Linde、PwC Legal、Gruner and Jahrなどの企業で要職を務めました。使用言語はドイツ語と英語です。
専門性
科学を支える、人。
放射線腫瘍学、医学物理学、ホウ素化学、国境を越えた産業界の16名のリーダーがBNCT Globalを支えています。
Paul M. Busse
Joseph W. Cotchett Endowed Chair in Radiation Oncology
Joseph W. Cotchett Endowed Chair in Radiation Oncology, MGH, and Associate Professor, Harvard Medical School
Paul M. Busse
M.D., Ph.D., FASTRO. He completed his residency in Radiation Medicine at MGH, Harvard Medical School, and until 2003 was lead physician and Principal Investigator for the Harvard MIT BNCT Program. Chief of the Head and Neck Service and Clinical Director in the Department of Radiation Oncology at MGH, and a member of the NCCN Head and Neck Panel. Recognised as an ASTRO Fellow in 2018, an honor held by fewer than 3 percent of the membership.
Huan Giap
Chief Medical Officer
Chief Medical Officer, ART and Integrated Proton Solutions, and Clinical Professor, University of Illinois College of Medicine Peoria
Huan Giap
Clinical Professor at the University of Illinois College of Medicine Peoria and Chief Medical Officer at ART and Integrated Proton Solutions. Former Director of Proton Therapy at the University of Miami Sylvester Comprehensive Cancer Center and former Chief of GI, Lung and Breast at the Scripps Proton Therapy Center. Co editor in chief of Translational Cancer Research. He completed the M.D. Ph.D. Medical Scientist Training Program with a PhD in Medical Physics at UT MD Anderson Cancer Center in 1994.
Evamarie Hey-Hawkins
Professor of Inorganic Chemistry (retired)
Professor of Inorganic Chemistry (retired), Leipzig University, and Vice President, German Society on BNCT
Evamarie Hey-Hawkins
Professor of Inorganic Chemistry at Leipzig University from 1993 to 2023, now at its Institute of Bioanalytical Chemistry. A Fellow of the Royal Society of Chemistry and member of Academia Europaea, with awards including the IUPAC Distinguished Woman in Chemistry Award and the Karl Ziegler Prize. She has published more than 650 articles and supervised over 100 doctoral graduates, and is Vice President of the German Society on Boron Neutron Capture Therapy. Her focus is biologically active boron and metal compounds for medicinal use.
Georg Löer
Founder
Founder, President and Representative Director, EURO-JAPAN Corporate Advisors Inc.
Georg Löer
Founder and President of EURO-JAPAN Corporate Advisors Inc., a consulting firm for business and market entry between Japan, Europe and the United States. He formerly headed NRW Japan K.K., the Japan office of the trade and investment agency of North Rhine-Westphalia, after senior banking roles in Germany, Japan, Indonesia and China. He focuses on startups and businesses in energy, sustainability and medtech, and studied economics and Japanese studies in Tübingen, Berlin and Tokyo.
Thomas Rock Mackie
Professor Emeritus of Medical Physics and Human Oncology
Professor Emeritus of Medical Physics and Human Oncology, University of Wisconsin-Madison
Thomas Rock Mackie
Professor Emeritus at the University of Wisconsin-Madison and a serial entrepreneur. Co founder of TomoTherapy, of HealthMyne, and of Leo Cancer Care, and co founder of Geometrics Corporation, whose Pinnacle treatment planning system became one of the largest selling in the world. Commissioner and Vice Chair of the ICRU. Awarded the ASTRO Gold Medal in 2019 for his service to radiation oncology.
Patrick S. Martin
Attorney at Law and Venture Capital Investor
Attorney at Law and Venture Capital Investor, Berlin
Patrick S. Martin
Attorney at law and venture investor in Berlin, running Oceanview Capital, advising family offices and mid size corporates on innovation and investment strategy. From 2007 to 2020 a Senior Vice President at DPDHL Group, where he built the corporate incubations department and the international ecommerce operations for DHL Globalmail from Singapore and Tokyo. He holds an MBA from the Graduate School of Business in Cape Town and studied at the Anderson School at UCLA.
Mitsuko Masutani
Professor
Professor, Graduate School of Biomedical Sciences, Nagasaki University
Mitsuko Masutani
Ph.D. researching DNA damage response, radiation biology and cancer treatment including BNCT. Coordinator of the Japanese Society of Neutron Capture Therapy and former head of the Division of Genome Stability Research at the National Cancer Center Research Institute in Tokyo. She led the preclinical research at the BNCT facility of the National Cancer Center Hospital toward permission to treat patients there.
Eiji Matsuura
Professor Emeritus
Professor Emeritus, Okayama University
Eiji Matsuura
Eiji Matsuura graduated from Okayama University Graduate School of Pharmaceutical Sciences and earned his PhD from Okayama University Graduate School of Medicine. After research posts in Denver, at Yamasa Corporation and at Hokkaido University, he returned to Okayama in 1997 as a professor at its Collaborative Research Center and Neutron Therapy Research Center. Now Professor Emeritus and Special Appointed Professor, his work spans cancer and autoimmune pathophysiology, drug delivery systems for BNCT, and molecular imaging and theranostics. He is co founder and Managing Director of Cardiovascular Solutions and Innovations LLC in the United States and CEO of CSI Global Health, an Okayama University start up.
Jean-Philippe Pignol
Senior Vice President
Senior Vice President, Chief Medical and Technology Officer, Accuray
Jean-Philippe Pignol
MD in Radiation Oncology and PhD in Nuclear Physics from Strasbourg University, on neutron capture therapy. He began at the Centre Antoine Lacassagne in Nice and the Institut Gustave Roussy in Paris and served as secretary to the EORTC BNCT Group. Former Professor and Chair of Radiation Oncology at Erasmus MC Rotterdam and medical co director of HollandPTC. In 2021 he joined Accuray as Senior Vice President and Chief Medical and Technology Officer.
Lucie Sancey
Director of Research
Director of Research, CNRS, Institute for Advanced Biosciences, Grenoble
Lucie Sancey
Director of Research of the CNRS at the Institute for Advanced Biosciences in Grenoble, leading the Translational Theranostic Team. Her work develops nano agents for cancer imaging and therapy, in particular for BNCT, and image guided surgery, with translational work taken into clinical trials. Author of more than 120 communications, holder of 5 patents and co founder of 3 start ups. President of the SFNano board, the French Society of Nanomedicine, and a member of the German BNCT Society.
Eduardo Daniel Santos
Director of Research Emeritus
Director of Research Emeritus, CNRS-IN2P3 and Grenoble-Alpes University
Eduardo Daniel Santos
Director of Research Emeritus at CNRS-IN2P3 and Grenoble-Alpes University, heading a platform on directional dark matter search, fast neutron spectroscopy and accelerator based neutron capture therapy at the Laboratory of Subatomic Physics and Cosmology. He previously managed the sorption cooler electronics for the Planck space mission. An expert on neutron dosimetry and field characterisation, he has supervised 15 PhD theses.
Reinhard Schulte
Full Professor of Radiation Medicine
Full Professor of Radiation Medicine, Loma Linda University
Reinhard Schulte
Physics diploma from the University of Dortmund and a doctorate in medicine from the University of Cologne, with a residency in radiology and radiation oncology at Hannover Medical School. After more than 20 years of medical practice in proton therapy, a Full Professor at Loma Linda University. He develops novel instrumentation and algorithms for proton therapy and promotes a new era of neutron capture therapy at his university and beyond.
Lembit Sihver
Founder and CTO
Founder and CTO, Cosmic Shielding Corporation, and Professor of Subatomic and Plasma Physics, Chalmers University of Technology
Lembit Sihver
Founder and CTO of Cosmic Shielding Corporation, Director of the CRREAT project at the Nuclear Physics Institute of the Czech Academy of Sciences, and Professor at Chalmers University of Technology. Former Head of Nuclear Science and Engineering at Chalmers and former Head of the Department of Radiation Physics at TU Wien, where he also led applied medical physics research at the MedAustron ion beam therapy center. Four decades in medical radiation physics, with collaborations across NASA, ESA and JAXA.
Rolf Stähelin
Founder and President
Founder and President, Staila Polaris MedTech GmbH, and former senior executive, Varian Medical Systems
Rolf Stähelin
A seasoned executive in the global radiotherapy industry with over three decades of experience. He held senior executive roles in the Oncology Systems business of Varian Medical Systems, now part of Siemens Healthineers. He is founder and president of Staila Polaris MedTech GmbH, a Swiss consulting firm supporting clinical and industry clients in market development, access, marketing and sales in radiotherapy, and is committed to accelerating the clinical adoption of BNCT.
Birgit Wortmann
Nuclear Engineer and invited expert
Nuclear Engineer and invited expert, European Commission
Birgit Wortmann
Dr.-Ing. with deep expertise in radiation transport calculations using Monte Carlo and deterministic codes, applied to licensing, decommissioning and optimised shielding for radioactive nuclides used in cancer therapy. More than 25 years in leading positions in nuclear service and power generation, with international projects across India, Turkey, the UK, Ireland, the US and Brazil. She earned her PhD by designing an irradiation facility for BNCT on autotransplanted organs, and since 2018 works independently as a consultant, lecturer and invited expert for the European Commission.
Florian Husen
Founder and CEO
Founder and CEO, MANERI
Florian Husen
Florian Husen is the founder and CEO of MANERI, a venture builder that develops brands in AI and digital marketing, including the agency x10a. He advises medical and research organisations on building their digital presence and lectures on digitalisation for medical practices at the Zahnärztekammer Bremen. He created and manages the BNCT Global website.
コミュニティ
DGBNCTのスポンサーとして。
BNCT Globalは、ドイツホウ素中性子捕捉療法学会（DGBNCT）のスポンサーとして、エッセンから臨床BNCTの発展を支えています。
次回学術大会：日程未定 · ヴュルツブルク